Starling Oncology, Inc. (STLNW) stock
STLNWNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as DFPH, STLN
$0.03+0.00 (+10.87%)
Close on Oct 30, 2026Market cap $665.51MP/E –Yield –
Starling Oncology cash
Cash and short-term investments held at the end of each period.
Starling Oncology's cash was $41.09M at Jun 30, 2026. For fiscal 2025 it was $33.57M, down 32.4% from the year before. The highest annual figure on record is $115.17M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $33.57M | -32.4% |
| FY2024 | Dec 31, 2024 | $49.67M | -40.1% |
| FY2023 | Dec 31, 2023 | $82.86M | +12.3% |
| FY2022 | Dec 31, 2022 | $73.81M | -35.9% |
| FY2021 | Dec 31, 2021 | $115.17M | +1820.2% |
| FY2020 | Dec 31, 2020 | $6.00M | +145.2% |
| FY2019 | Dec 31, 2019 | $2.45M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $41.09M | +35.7% |
| Q1 FY2026 | Mar 31, 2026 | $30.28M | -23.8% |
| Q4 FY2025 | Dec 31, 2025 | $33.57M | -32.4% |
| Q3 FY2025 | Sep 30, 2025 | $27.66M | -41.7% |
| Q2 FY2025 | Jun 30, 2025 | $30.29M | -34.7% |
| Q1 FY2025 | Mar 31, 2025 | $39.74M | -39.6% |
| Q4 FY2024 | Dec 31, 2024 | $49.67M | -40.1% |
| Q3 FY2024 | Sep 30, 2024 | $47.40M | -45.8% |
| Q2 FY2024 | Jun 30, 2024 | $46.36M | +18.3% |
| Q1 FY2024 | Mar 31, 2024 | $65.83M | +18.9% |
| Q4 FY2023 | Dec 31, 2023 | $82.86M | +12.3% |
| Q3 FY2023 | Sep 30, 2023 | $87.41M | -3.5% |
| Q2 FY2023 | Jun 30, 2023 | $39.18M | -39.0% |
| Q1 FY2023 | Mar 31, 2023 | $55.38M | -42.0% |
| Q4 FY2022 | Dec 31, 2022 | $73.81M | -35.9% |
| Q3 FY2022 | Sep 30, 2022 | $90.58M | +685.5% |
| Q2 FY2022 | Jun 30, 2022 | $64.21M | +323.3% |
| Q1 FY2022 | Mar 31, 2022 | $95.53M | +248.5% |
| Q4 FY2021 | Dec 31, 2021 | $115.17M | +1820.2% |
| Q3 FY2021 | Sep 30, 2021 | $11.53M | +1054.9% |
| Q2 FY2021 | Jun 30, 2021 | $15.17M | +1275.1% |
| Q1 FY2021 | Mar 31, 2021 | $27.41M | +1718.5% |
| Q4 FY2020 | Dec 31, 2020 | $6.00M | +145.2% |
| Q3 FY2020 | Sep 30, 2020 | $998.57K | – |
| Q2 FY2020 | Jun 30, 2020 | $1.10M | – |
| Q1 FY2020 | Mar 31, 2020 | $1.51M | – |
| Q4 FY2019 | Dec 31, 2019 | $2.45M | – |